In this study, we developed prognostic models for CRC recurrence using machine learning models on a limited number of CEA measurements.<h4>Method</h4>A dataset of 1927 patients diagnosed with Stage I-III CRC and referred to Zuyderland Hospital for surgery between 2008 and 2016 was utilized. This evidence concerns the gene CEACAM5 and colorectal carcinoma.